Prof. Kehong Chen | Innovative Leadership | Best Researcher Award

Published on by Leadership and Management

Prof. Kehong Chen | Innovative Leadership | Best Researcher Award

Department of Nephrology, Daping Hospital | China

Chen Kehong, MD, PhD, is a Professor of Nephrology and Deputy Director of the Department of Nephrology at Daping Hospital, Army Medical University, where he also serves as a doctoral supervisor. He received his medical and doctoral training in nephrology and internal medicine and has developed an academic career combining clinical leadership with translational research. His professional experience includes directing regional quality control initiatives in peritoneal dialysis and leading collaborative dialysis alliances in Southwest China. Actively involved in national and regional academic societies, he contributes to discipline development, guideline promotion, and talent cultivation in nephrology. His research interests focus on acute kidney injury to chronic kidney disease transition, diabetic kidney disease, renal inflammation, mitochondrial dysfunction, autophagy/mitophagy, epigenetic regulation, and blood purification therapies, with sustained funding from the National Natural Science Foundation of China and regional innovation programs. He has published extensively in high-impact journals, contributing influential findings to renal pathophysiology and immunometabolism. His achievements have been recognized through multiple provincial science and technology awards and talent honors. Overall, Professor Chen is regarded as a clinician-scientist whose integrated leadership, research excellence, and commitment to advancing kidney medicine continue to shape nephrology practice and innovation in China.

Profile:  ORCID

Featured Publications

Dou, Q., Tong, H., Chen, J., Yi, X., Bai, L., He, J., & Chen, K. (2025). IER3 drives the transition from sepsis-associated acute kidney injury to chronic kidney disease by suppressing the mitochondrial translocation of PRDX5. Cellular and Molecular Life Sciences, Advance online publication.

Han, J., Zhang, S., Hou, Y., Wang, Y., Zhang, Z., Yang, J., Xu, Y., Peng, Z., Yin, H., & Chen, K. et al. (2025). A chemical agonist and the Golgi-resident lipid PI4P activate STING by inducing transmembrane helix rearrangement. Immunity, Advance online publication.

Yu, F., Meng, Y., Wang, X., Chen, J., He, J., Yi, X., He, Y., & Chen, K. (2025). Protein lactylation of citrate synthase promotes the AKI–CKD transition by activating the NLRP3 inflammasome. Cell Reports, Advance online publication.

Chen, J., Wang, W., Yu, F., Wang, X., He, Y., & Chen, K. (2025). Urinary DcR2/Cr level predicts renal outcomes in patients with diabetic kidney disease. Journal of Clinical & Translational Endocrinology, Advance online publication.

Yu, F., Chen, J., Wang, X., Hou, S., Li, H., Yao, Y., He, Y., & Chen, K. (2025). Metabolic reprogramming of peritoneal mesothelial cells in peritoneal dialysis-associated fibrosis: Therapeutic targets and strategies. Cell Communication and Signaling, Advance online publication.

Assoc. Prof. Dr. Sefa Tatar | Innovative Leadership | Innovator of the Year in Leadership Award

Published on by Leadership and Management

Assoc. Prof. Dr. Sefa Tatar | Innovative Leadership | Innovator of the Year in Leadership Award

Necmettin Erbakan University | Turkey

Author Profile

Scopus 

Early Academic Pursuits

From the outset of his medical journey, Dr. Sefa Tatar demonstrated a strong commitment to advancing his knowledge in the field of medicine, with a focus on cardiology. His foundational education at the Faculty of Medicine equipped him with rigorous scientific training and practical exposure to the complexities of human health. During this period, he developed a keen interest in cardiovascular diseases, recognizing their global prevalence and critical impact on public health. His determination to specialize further led him to pursue advanced medical training, culminating in a specialization in cardiology. His doctoral dissertation, which investigated the prognostic significance of diastolic global longitudinal strain rate in patients with heart failure, reflects his early commitment to research-driven practice. This period of study not only laid a robust theoretical foundation but also nurtured the analytical and clinical skills that would shape his later contributions to cardiology.

Professional Endeavors

Dr. Tatar’s professional career has been marked by steady progression through diverse healthcare and academic roles. He began his practice as a physician in a state hospital, where he gained invaluable firsthand experience managing patients across a spectrum of health conditions. His clinical responsibilities during this time exposed him to the challenges of delivering effective healthcare in diverse communities. Transitioning into academia as a research assistant in cardiology, he immersed himself in teaching, clinical duties, and scientific inquiry. This role honed his dual identity as both a physician and a scholar. Later, as a specialist physician in leading hospitals, he was entrusted with critical responsibilities in patient care and advanced diagnostics. These experiences enhanced his ability to integrate clinical expertise with research, ensuring evidence-based practices were at the forefront of his medical service. Currently serving as an academician in cardiology, he continues to balance patient care, teaching, and scholarly activities, positioning himself as a versatile contributor to the field.

Contributions and Research Focus

Central to Dr. Tatar’s professional identity is his dedication to advancing cardiology research. His work on diastolic global longitudinal strain rate represents a valuable contribution to understanding heart failure outcomes, an area of immense clinical importance given its association with morbidity and mortality. Through this research, he highlighted how specific echocardiographic parameters could predict mortality, rehospitalization, and hospital stay length, offering clinicians valuable insights into patient management. Beyond this, his scholarly focus has been closely tied to practical clinical challenges, ensuring that his research directly informs and improves patient care strategies. His teaching role also underscores his contributions, as he guides medical students through complex concepts in cardiology, nurturing the next generation of physicians with a blend of academic rigor and clinical wisdom.

Accolades and Recognition

Throughout his academic and professional trajectory, Dr. Tatar has earned recognition for his expertise and contributions within the cardiology community. His membership in prestigious organizations such as the Turkish Society of Cardiology, the European Society of Cardiology, and the American Society of Cardiology attests to his standing as an active participant in the global exchange of scientific knowledge. These affiliations provide him with platforms to contribute to international dialogues, collaborate with peers, and stay abreast of cutting-edge advancements in cardiovascular medicine. His inclusion in such societies reflects both his credibility as a researcher and his dedication to professional growth within the discipline.

Impact and Influence

Dr. Tatar’s impact extends across multiple spheres—clinical care, academic teaching, and scientific research. His work bridges the gap between research outcomes and bedside practice, ensuring that patients benefit from the most current evidence-based approaches. In the classroom, he influences aspiring physicians by instilling in them the importance of critical thinking and scientific inquiry, shaping future professionals who will carry forward his ethos of combining compassion with precision. Within the research community, his focus on predictive markers in heart failure adds to the growing body of knowledge that informs treatment protocols and healthcare policies. Collectively, these contributions highlight his role as a thought leader and mentor within cardiology.

Legacy and Future Contributions

Looking ahead, Dr. Tatar’s trajectory suggests a continued commitment to advancing cardiology through both research and practice. His academic career provides a strong platform for producing innovative studies that address unresolved challenges in cardiovascular medicine. With his grounding in both clinical practice and scientific research, he is poised to contribute to new diagnostic tools, prognostic models, and therapeutic strategies that can transform patient outcomes. Additionally, his dedication to teaching ensures that his legacy will be carried forward by students and colleagues who benefit from his mentorship. His future contributions are likely to resonate not only within his immediate professional circles but also across the broader global cardiology community, where innovative approaches to patient care and disease management are urgently needed.

Notable Publications

Association of serum copeptin levels with pulmonary complications and heart right ventricular functions in common variable immunodeficiency

Authors: Not listed in your excerpt
Journal: BMC Immunology
Year: 2025

Diastolic global longitudinal strain and acute ischemic stroke: a hidden relationship?

Authors: Not listed in your excerpt
Journal: BMC Cardiovascular Disorders
Year: 2025

Conclusion

Dr. Sefa Tatar’s journey reflects the seamless integration of academic excellence, clinical expertise, and research innovation. From his early academic pursuits through his professional endeavors in healthcare institutions and academia, he has consistently demonstrated a deep commitment to advancing cardiology. His research contributions, professional recognition, and influence on both students and patients underscore his significance in the field. With a strong foundation and clear vision for the future, his work promises to leave a lasting legacy in cardiovascular medicine while shaping future directions in research, teaching, and clinical practice.

Assist Prof Dr. Taku Ishii | Decision-making and Problem-solving | Best Research Article Award

Published on by Leadership and Management

Assist Prof Dr. Taku Ishii | Decision-making and Problem-solving | Best Research Article Awar

Institute of Science Tokyo | Japan

Author Profile

ORCID

Early Academic Pursuits

Taku Ishii’s academic path reflects a focused dedication to understanding and addressing complex pediatric cardiovascular diseases. From the outset of his medical education, he was drawn to the intricacies of pediatric cardiology, a specialty that demands both technical precision and a deep sense of compassion. His early clinical training allowed him to develop expertise in diagnosing and managing congenital heart disease and pulmonary hypertension, conditions that profoundly affect the lives of young patients and their families. Seeking to enhance his approach to patient care, he pursued graduate studies in public health, which broadened his perspective beyond individual treatment toward the systemic and epidemiological aspects of healthcare. This unique combination of clinical and public health training equipped him with a multifaceted approach to pediatric cardiology, enabling him to address not only the biological mechanisms of disease but also the societal factors influencing patient outcomes.

Professional Endeavors

In his current role as an Assistant Professor at the Institute of Science Tokyo, Taku Ishii operates at the intersection of clinical practice, academic instruction, and research leadership. As a clinician, he provides specialized care to children with life-threatening and complex cardiac conditions, applying innovative treatment strategies to improve long-term health outcomes. His academic contributions involve mentoring medical students and residents, fostering their clinical judgment, technical skills, and dedication to compassionate care. Beyond the classroom and hospital, he actively participates in the Japanese Association of Congenital Heart Disease with Pulmonary Hypertension (JACPHR), contributing to collaborative research and nationwide efforts to advance understanding and management of these conditions. His professional life is characterized by a commitment to advancing patient care while building the capacity of the next generation of pediatric cardiologists.

Contributions and Research Focus

Taku Ishii’s research portfolio reflects his dual commitment to scientific advancement and clinical relevance. His studies encompass molecular biology, clinical cardiology, and epidemiology, creating a holistic body of work that addresses both the mechanisms and management of pediatric heart diseases. His co-authored research in The FASEB Journal explores the role of Hedgehog signaling in the development of pulmonary arterial hypertension, identifying cyclopamine as a potential therapeutic agent to mitigate disease progression. His work published in Cureus examines the role of implantable cardioverter defibrillators in preventing sudden cardiac death in children with arrhythmogenic right ventricular cardiomyopathy, providing much-needed data to guide treatment in pediatric populations. Additionally, his collaboration in the Journal of Human Genetics documents novel cases of HYAL2 deficiency, linking genetic variations to different clinical severities, and reinforcing the integration of genetic insights into pediatric cardiology. Through these contributions, he advances both the understanding of disease mechanisms and the development of patient-centered therapeutic strategies.

Accolades and Recognition

Taku Ishii’s achievements have earned him professional recognition within both national and international medical communities. His appointment as an assistant professor at the Institute of Science Tokyo underscores his standing as a respected academic and clinician. His publications in high-impact, peer-reviewed journals demonstrate the scientific rigor and clinical relevance of his work, contributing to ongoing global conversations in pediatric cardiology. His active involvement in collaborative research networks, such as the JACPHR, not only highlights his commitment to team-based science but also positions him as a valued contributor to the advancement of pediatric cardiac care. These acknowledgments reflect the trust placed in his expertise and his role in influencing the future direction of his field.

Impact and Influence

The influence of Taku Ishii’s work is evident in both direct patient care and the broader advancement of pediatric cardiology. Clinically, his interventions have improved the lives of children with complex and often life-threatening cardiac conditions. Academically, his teaching and mentorship shape the perspectives and capabilities of emerging pediatric specialists, instilling in them the values of precision, empathy, and evidence-based practice. His research, grounded in both clinical and public health perspectives, informs treatment guidelines and contributes to national health strategies aimed at better managing pediatric cardiovascular diseases. By bridging molecular research with patient care and policy considerations, he has established himself as a central figure in ensuring that scientific advances translate into tangible improvements in health outcomes.

Legacy and Future Contributions

Looking ahead, Taku Ishii is well-positioned to continue driving innovation in pediatric cardiology through cutting-edge research and collaborative initiatives. His ongoing studies in pulmonary hypertension and congenital heart disease have the potential to yield new diagnostic tools and therapeutic approaches, ultimately improving survival rates and quality of life for affected children. His interest in genetic research is likely to further integrate precision medicine into pediatric care, paving the way for individualized treatment strategies. Equally important is his role as an educator and mentor, ensuring that his knowledge and values are passed on to future generations of physicians and researchers. His legacy will be defined by both his scientific contributions and his enduring influence on the medical professionals he has trained and inspired.

Notable Publications

Pharmacological Treatment Practices for Patients with Congenital Heart Disease and Pulmonary Hypertension in Japan: Insights from the Japanese Association of Congenital Heart Disease Registry (JACPHR)

Authors: Taku Ishii; Keiko Uchida; Susumu Hosokawa; Reina Ishizaki; Naofumi F Sumitomo; Yoshiyuki Furutani; Hidekazu Ishida; Shinichi Takatsuki; Kei Inai; Kunihiko Takahashi et al.
Journal: The American Journal of Cardiology
Year: 2025

Marked improvement in severe pulmonary arterial hypertension following airway infection in a patient with a heterozygous BMP9 nonsense mutation: A case report

Authors: Taku Ishii; Makito Sakurai; Yohei Yamaguchi; Kei Takasawa; Susumu Hosokawa
Journal: — (Other publication type)
Year: 2025

Challenges in Accurately Assessing Acute Vasoreactivity in Pediatric Pulmonary Arterial Hypertension: Case Reports Highlighting the Impact of Sedation on Diagnostic Accuracy

Authors: Kana Inoue; Taku Ishii; Yohei Yamaguchi; Satoshi Nagahara; Makito Sakurai; Susumu Hosokawa; Shozaburo Doi; Diego Araiza-Garaygordobil
Journal: European Heart Journal – Case Reports
Year: 2025

Exploring viral infections’ role in Kawasaki disease onset: A study during the COVID‐19 pandemic

Authors: Taku Ishii; Nobutoshi Nawa; Susumu Hosokawa; Tomohiro Morio; Takeo Fujiwara
Journal: Journal of Medical Virology
Year: 2024

Association between the initiation of insurance coverage for fetal echocardiography and mortality from congenital heart disease in infants: An interrupted time series analysis

Authors: Taku Ishii; Nobutoshi Nawa; Shozaburo Doi; Tomohiro Morio; Takeo Fujiwara
Journal: Paediatric and Perinatal Epidemiology
Year: 2023

Conclusion

Taku Ishii’s career embodies the integration of clinical excellence, academic leadership, and research innovation. His journey from focused academic preparation to impactful professional practice demonstrates a sustained commitment to improving the lives of children with complex cardiac conditions. Through his clinical care, he offers hope and healing to patients and families; through his research, he advances the understanding and treatment of pediatric heart diseases; and through his mentorship, he shapes the future of the field. His work stands as a testament to the power of combining science, compassion, and education to create meaningful and lasting change in medicine.

Dr. Fatemeh Tahmasebi | Innovative Leadership | Best Researcher Award

Published on by Leadership and Management

Dr. Fatemeh Tahmasebi | Innovative Leadership | Best Researcher Award

Department of Anatomy, Faculty of Medicine | Iran

Author Profile

Google Scholar 

Early Academic Pursuits

Dr. Fatemeh Tahmasebi began her academic journey with a strong focus on the medical sciences, specializing in the intricate field of human anatomy. Her academic pursuits were rooted in deep scientific curiosity, which laid the foundation for her future as a research-driven academic. Her doctoral studies concentrated on anatomical sciences, a discipline that demands both rigorous theoretical knowledge and exceptional laboratory proficiency. These formative years were critical in shaping her understanding of the complexities of the human nervous system, cellular interactions, and regenerative medicine—areas that would later become central to her research identity.

Professional Endeavors

Currently serving as an Assistant Professor at the School of Medicine, Mashhad University of Medical Sciences, Dr. Tahmasebi has established herself as a dedicated academic and researcher. In her role as a faculty member, she not only contributes to the education of medical students but also actively mentors research scholars in highly technical, experimental studies. Her professional career has been consistently aligned with high-impact areas in neuroanatomy and tissue engineering, with particular focus on spinal cord injuries, neurodegeneration, and neural regeneration. She has demonstrated exceptional leadership in numerous research projects, often taking on the role of executive investigator, managing all aspects of experimental design, implementation, and data analysis.

Contributions and Research Focus

Dr. Tahmasebi’s research portfolio is both extensive and multidisciplinary, merging neurobiology, stem cell therapy, nanotechnology, and regenerative medicine. She has made significant strides in developing innovative approaches to treating spinal cord injuries and neurodegenerative diseases using adipose-derived mesenchymal stem cells, nanofiber scaffolds, and targeted drug delivery systems. Her research projects include studies on the phenotypic modulation of glial cells, the interaction of neurons and astrocytes in disease models, and the use of nanotechnology to enhance the efficacy of regenerative treatments.

One of her hallmark contributions is the use of polymeric and carbon nanotube-based scaffolds enriched with therapeutic agents like curcumin, hesperidin, and ellagic acid to enhance recovery in spinal cord injury models. Additionally, she has led groundbreaking investigations into the role of microRNAs in neural degeneration, especially in Parkinson’s disease and multiple sclerosis models. Her pioneering work on the use of exosome-loaded hydrogels for targeted drug delivery exemplifies her dedication to translational research that bridges the gap between basic science and clinical application.

Dr. Tahmasebi’s research also extends to developmental neuroscience. She has explored how maternal diabetes impacts the expression of neurotransmitter receptors in neonates, offering insights into developmental neurobiology and the intergenerational effects of metabolic disorders.

Accolades and Recognition

Her scientific achievements are reflected in her prolific publication record in peer-reviewed, high-impact journals indexed in ISI, Scopus, PubMed, and other international databases. Many of her articles have been published in reputed journals such as the Journal of Cellular Physiology, Neuropeptides, Journal of Molecular Histology, Journal of Cellular Biochemistry, Cell Journal, and Journal of Chemical Neuroanatomy. In these works, she often appears as the first or corresponding author, demonstrating her leadership in research conceptualization and execution.

Beyond publications, Dr. Tahmasebi has also collaborated on several major research projects, bringing together expertise across multiple institutions and research centers. Her role as a co-investigator in numerous studies reflects her capacity to contribute both technically and intellectually to multidisciplinary scientific efforts.

Impact and Influence

Dr. Tahmasebi’s work has had a meaningful impact on both academic scholarship and biomedical research related to neuroregeneration. Her focus on integrating stem cell biology with nanomedicine to treat conditions like multiple sclerosis and spinal cord injuries addresses urgent global health challenges. Her research on microglial and astrocyte modulation has helped deepen understanding of the cellular microenvironment during neurodegeneration and repair. By advancing therapies that utilize bioengineered scaffolds and exosomes, she is actively shaping the future of neural tissue engineering and personalized regenerative medicine.

Furthermore, her contributions have inspired a new generation of researchers, particularly in Iran, to pursue high-level, applied biomedical research. Through her involvement in postgraduate mentorship and interdisciplinary collaborations, she is helping to build research capacity and elevate the scientific standards in anatomical and neurological sciences.

Legacy and Future Contributions

Dr. Fatemeh Tahmasebi’s academic legacy is one of innovation, collaboration, and commitment to societal health. Her work stands at the crossroads of anatomical science, regenerative medicine, and nanotechnology. As research in neural repair and neuroplasticity continues to evolve, she is well-positioned to lead new initiatives in translational neuroscience. Her future endeavors are likely to include the development of bioresponsive scaffolds, gene regulation therapies via miRNAs, and deeper investigations into neuroimmune interactions during injury recovery.

She is poised to further influence medical science not only through pioneering research but also through active engagement in scientific dissemination and community health education. Her continued presence in academia and research will undoubtedly contribute to a deeper understanding of complex neurobiological processes and the development of more effective therapeutic strategies.

Notable Publications

Effect of the CSF1R inhibitor PLX3397 on remyelination of corpus callosum in a cuprizone‐induced demyelination mouse model

Authors: F. Tahmasebi, P. Pasbakhsh, K. Mortezaee, S. Madadi, S. Barati, I.R. Kashani
Journal: Journal of Cellular Biochemistry
Year: 2019

Masitinib: The promising actor in the next season of the Amyotrophic Lateral Sclerosis treatment series

Authors: A.H.M.E. Ketabforoush, R. Chegini, S. Barati, F. Tahmasebi, B. Moghisseh, …
Journal: Biomedicine & Pharmacotherapy
Year: 2023

Mesenchymal stem cell mediated effects on microglial phenotype in cuprizone‐induced demyelination model

Authors: S. Barati, I. Ragerdi Kashani, F. Moradi, F. Tahmasebi, S. Mehrabi, M. Barati, …
Journal: Journal of Cellular Biochemistry
Year: 2019

Astrocyte ablation induced by La-aminoadipate (L-AAA) potentiates remyelination in a cuprizone demyelinating mouse model

Authors: S. Madadi, P. Pasbakhsh, F. Tahmasebi, K. Mortezaee, M. Khanehzad, …
Journal: Metabolic Brain Disease
Year: 2019

The effect of microglial ablation and mesenchymal stem cell transplantation on a cuprizone‐induced demyelination model

Authors: F. Tahmasebi, P. Pasbakhsh, S. Barati, S. Madadi, I.R. Kashani
Journal: Journal of Cellular Physiology
Year: 2021

Mr. Tongzhen Si | Innovative Leadership | Young Scientist Award

Published on by Leadership and Management

Mr. Tongzhen Si | Innovative Leadership | Young Scientist Award

🔗 Professional Profiles

Summary

Tongzhen Si is a dedicated researcher in computer vision and image processing, with a Ph.D. from Wuhan University. They currently contribute to scientific research at Jinan University and have a robust publication record.

Education

🎓 Ph.D. in Computer Science and Technology
🗓️ Wuhan University, China (June 2023)
🏆 Awarded an excellent doctorate

Professional Experience

👩‍🔬 Researcher
🗓️ Jinan University, China (2023-Present)
📚 Engaged in scientific research in the fields of computer vision and image processing

Research Interests

🔍 Computer Vision
📸 Image Processing

Tongzhen Si’s work in these areas has resulted in the publication of 25 academic papers, including 2 highly cited papers, contributing significantly to the advancement of these fields

Publication Top Noted

Semantic-aware Transformer with Feature Integration for Remote Sensing Change Detection

    • Authors: Li, P., Si, T., Ye, C., Guo, Q.
    • Journal: Engineering Applications of Artificial Intelligence
    • Volume: 135
    • Issue: –
    • Pages: 108774
    • Year: 2024

Homogeneous and Heterogeneous Optimization for Unsupervised Cross-Modality Person Reidentification in Visual Internet of Things

    • Authors: Si, T., He, F., Li, P., Ye, M.
    • Journal: IEEE Internet of Things Journal
    • Volume: 11
    • Issue: 7
    • Pages: 12165–12176
    • Year: 2024

Homogeneous and Heterogeneous Optimization for Unsupervised Cross-Modality Person Reidentification in Visual Internet of Things

    • Authors: Si, T., He, F., Li, P., Ye, M.
    • Journal: IEEE Internet of Things Journal
    • Volume: 11
    • Issue: 7
    • Pages: 12165–12176
    • Year: 2024

A Decomposition-based Many-objective Evolutionary Algorithm with Weight Grouping and Adaptive Adjustment

    • Authors: Gao, X., He, F., Luo, J., Si, T.
    • Journal: Memetic Computing
    • Volume: 16
    • Issue: 1
    • Pages: 91–113
    • Year: 2024

UnifiedSC: A Unified Framework via Collaborative Optimization for Multi-task Person Re-identification

    • Authors: Si, T., He, F., Li, P.
    • Journal: Applied Intelligence
    • Volume: 54
    • Issue: 4
    • Pages: 2962–2975
    • Year: 2024